Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
Appetite
|
October 16, 2020
A randomized controlled trial testing the effects of a positive front-of-pack label with or without a physical activity equivalent label on food purchases
Eric A Finkelstein, Brett Doble, Felicia Jia Ler Ang, et al.
Nutrients
|
September 20, 2019
A Randomized Controlled Trial Evaluating the Relative Effectiveness of the Multiple Traffic Light and Nutri-Score Front of Package Nutrition Labels
Eric A Finkelstein, Felicia Jia Ler Ang, Brett Doble, et al.
JAMA Ophthalmology
|
January 10, 2020
Cost-effectiveness of Intravitreal Ranibizumab With Verteporfin Photodynamic Therapy Compared With Ranibizumab Monotherapy for Patients With Polypoidal Choroidal Vasculopathy
Brett Doble, Eric Andrew Finkelstein, Yubing Tian, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 16, 2010
Prophylaxis of radiation-induced nausea and vomiting using 5-hydroxytryptamine-3 serotonin receptor antagonists: a systematic review of randomized trials
Nadia Salvo, Brett Doble, Luluel Khan, et al.
Pharmacoeconomics
|
August 7, 2025
Evaluating the Role and Policy Implications of Using External Evidence in Survival Extrapolations: A Case Study of Axicabtagene Ciloleucel Therapy for Second-Line DLBCL
Sam Harper, Daniela Afonso, Karina Watts, et al.
Frontiers in Immunology
|
June 10, 2024
Cost-effectiveness of treating relapsed or refractory 3L+ follicular lymphoma with axicabtagene ciloleucel vs mosunetuzumab in the United States
Olalekan O Oluwole, Markqayne D Ray, Richard M Zur, et al.
BMJ Open
|
July 14, 2019
Cardiovascular magnetic resonance in emergency patients with multivessel disease or unobstructed coronary arteries: a cost-effectiveness analysis in the UK
Elizabeth A Stokes, Brett Doble, Maria Pufulete, et al.
Health Technology Assessment (Winchester, England)
|
December 23, 2017
Clinical effectiveness and cost-effectiveness of issuing longer versus shorter duration (3-month vs. 28-day) prescriptions in patients with chronic conditions: systematic review and economic modelling
Céline Miani, Adam Martin, Josephine Exley, et al.
Journal of Medical Economics
|
February 18, 2026
Time to access matters: patient gains from faster CAR T-cell reimbursement in Europe
Yan Zhi Tan, Emily Breislin, Matthew Woods, et al.
MDM Policy & Practice
|
October 6, 2018
Economic Evaluation Alongside a Randomized Controlled Crossover Trial of Modified Group Cognitive-Behavioral Therapy for Anxiety Compared to Treatment-as-Usual in Adults With Asperger Syndrome
Brett Doble, Peter E Langdon, Lee Shepstone, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
Appetite
|
October 16, 2020
A randomized controlled trial testing the effects of a positive front-of-pack label with or without a physical activity equivalent label on food purchases
Eric A Finkelstein, Brett Doble, Felicia Jia Ler Ang, et al.
Nutrients
|
September 20, 2019
A Randomized Controlled Trial Evaluating the Relative Effectiveness of the Multiple Traffic Light and Nutri-Score Front of Package Nutrition Labels
Eric A Finkelstein, Felicia Jia Ler Ang, Brett Doble, et al.
JAMA Ophthalmology
|
January 10, 2020
Cost-effectiveness of Intravitreal Ranibizumab With Verteporfin Photodynamic Therapy Compared With Ranibizumab Monotherapy for Patients With Polypoidal Choroidal Vasculopathy
Brett Doble, Eric Andrew Finkelstein, Yubing Tian, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 16, 2010
Prophylaxis of radiation-induced nausea and vomiting using 5-hydroxytryptamine-3 serotonin receptor antagonists: a systematic review of randomized trials
Nadia Salvo, Brett Doble, Luluel Khan, et al.
Pharmacoeconomics
|
August 7, 2025
Evaluating the Role and Policy Implications of Using External Evidence in Survival Extrapolations: A Case Study of Axicabtagene Ciloleucel Therapy for Second-Line DLBCL
Sam Harper, Daniela Afonso, Karina Watts, et al.
Frontiers in Immunology
|
June 10, 2024
Cost-effectiveness of treating relapsed or refractory 3L+ follicular lymphoma with axicabtagene ciloleucel vs mosunetuzumab in the United States
Olalekan O Oluwole, Markqayne D Ray, Richard M Zur, et al.
BMJ Open
|
July 14, 2019
Cardiovascular magnetic resonance in emergency patients with multivessel disease or unobstructed coronary arteries: a cost-effectiveness analysis in the UK
Elizabeth A Stokes, Brett Doble, Maria Pufulete, et al.
Health Technology Assessment (Winchester, England)
|
December 23, 2017
Clinical effectiveness and cost-effectiveness of issuing longer versus shorter duration (3-month vs. 28-day) prescriptions in patients with chronic conditions: systematic review and economic modelling
Céline Miani, Adam Martin, Josephine Exley, et al.
Journal of Medical Economics
|
February 18, 2026
Time to access matters: patient gains from faster CAR T-cell reimbursement in Europe
Yan Zhi Tan, Emily Breislin, Matthew Woods, et al.
MDM Policy & Practice
|
October 6, 2018
Economic Evaluation Alongside a Randomized Controlled Crossover Trial of Modified Group Cognitive-Behavioral Therapy for Anxiety Compared to Treatment-as-Usual in Adults With Asperger Syndrome
Brett Doble, Peter E Langdon, Lee Shepstone, et al.
Page
of 5